PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year EBIT Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EBIT Growth(%) | 180.22 | -67.21 | -38.59 | - |
What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?
Year | EBIT Growth |
---|---|
Mar2024 | 180.22 |
Mar2023 | -67.21 |
Mar2022 | -38.59 |
Mar2021 | - |
How is EBIT Growth of PIRAMAL PHARMA Trending?
Years | EBIT Growth | % Change | |
---|---|---|---|
Mar2024 | 180.22 | Positive | |
Mar2023 | -67.21 | Negative | |
Mar2022 | -38.59 | 0 | |
Mar2021 | 0 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹27,374.9 Cr | 0.4% | -0.4% | 39.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -2% | -8.4% | 14.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,673.0 Cr | -0.2% | 7.5% | 48% | Stock Analytics | |
CIPLA | ₹118,908.0 Cr | -0.3% | -2.6% | 0.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,106.0 Cr | -1% | -4.1% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,494.0 Cr | 0.3% | 8% | 6.2% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 0.4% |
-0.4% |
39.9% |
SENSEX | -0.4% |
0.3% |
8.7% |
You may also like the below Video Courses